These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 35245011

  • 1. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency.
    Du H, Wu D, Yi P, Bai X, Luo Y, Yang H, Chen S, Pan H, Zhu H.
    J Pediatr Endocrinol Metab; 2022 Apr 26; 35(4):511-517. PubMed ID: 35245011
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan 26; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study.
    Hou L, Lin S, Liu Z, Zhang L, Ou H, Huang S, Dai H, Meng Z, Liang L.
    J Pediatr Endocrinol Metab; 2024 Oct 28; 37(10):892-899. PubMed ID: 39190198
    [Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetic/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals.
    Cheng R, Zhao Q, Zhong G, Xu J, Zheng Z, Xi L, Zhang M, Ni J, Hu P, Luo F, Lu W.
    Eur J Pharm Sci; 2022 Dec 01; 179():106304. PubMed ID: 36209987
    [Abstract] [Full Text] [Related]

  • 7. Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study.
    Hou L, Huang K, Gong C, Luo F, Wei H, Liang L, Du H, Zhang J, Zhong Y, Chen R, Chen X, Pan J, Jin X, Zeng T, Liao W, Liu D, Lan D, Zhu S, Dong Z, Ma H, Yang Y, Xiong F, Lu P, Cheng S, Gu X, Jin R, Liu Y, Wu J, Xu X, Chen L, Dong Q, Pan H, Su Z, Liu L, Luo X, Ni S, Chen Z, Hu Y, Wang C, Liu J, Liu L, Lu B, Wang X, Wang Y, Yang F, Zhang M, Cao L, Liu G, Yao H, Zhan Y, Dai M, Li G, Li L, Liu Y, Wang K, Xiao Y, Zhang X, Dong J, Gu Z, Ying L, Huang F, Liu Y, Liu Z, Ye J, Zhao D, Hu X, Jiang Z, Ye K, Zhu H, Chen S, Chen X, Wan N, Xu Z, Yin Q, Zhang H, Huang X, Yin J, Zhang H, Li P, Yin P, Fu J, Luo X.
    J Clin Endocrinol Metab; 2023 Jul 14; 108(8):2078-2086. PubMed ID: 36669772
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study.
    Xie L, Li Y, Zhang J, Guo S, Chen Q, Ma H, Jiang W.
    Eur J Pediatr; 2024 Oct 14; 183(10):4531-4539. PubMed ID: 39158594
    [Abstract] [Full Text] [Related]

  • 9. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
    Liang Y, Zhang C, Wei H, Du H, Zhang G, Yang Y, Zhang H, Gong H, Li P, Song F, Xu Z, He R, Zhou W, Zheng H, Sun L, Luo X.
    Front Endocrinol (Lausanne); 2022 Oct 14; 13():922304. PubMed ID: 36034448
    [Abstract] [Full Text] [Related]

  • 10. PEGylated Recombinant Human Growth Hormone Jintrolong® Exhibits Good Long-Term Safety in Cynomolgus Monkeys and Human Pediatric Growth Hormone Deficiency Patients.
    Wu W, Zhou J, Wu C, Zhou Q, Li X, Zhang Y, Zuo C, Yin J, Hou L, Wang S, Gao H, Luo T, Jin L, Zhong E, Wang Y, Luo X.
    Front Endocrinol (Lausanne); 2022 Oct 14; 13():821588. PubMed ID: 35909512
    [Abstract] [Full Text] [Related]

  • 11. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L, Chen ZH, Liu D, Cheng YG, Luo XP.
    Drug Des Devel Ther; 2016 Oct 14; 10():13-21. PubMed ID: 26719670
    [Abstract] [Full Text] [Related]

  • 12. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study.
    Jiang Z, Chen X, Dong G, Lou Y, Zhang J, Cheng X, Pan J, Liao W, Wu J, Huang X, Jin X, Liu D, Zeng T, Zhu S, Dong Q, Luo X, Lan D, Cao L, Zhang X, Liu J, Dai M, Zhang M, Liu L, Dong J, Zhao D, Ni S, Fu J.
    Front Pharmacol; 2022 Oct 14; 13():955809. PubMed ID: 36034802
    [Abstract] [Full Text] [Related]

  • 13. Long-acting PEGylated growth hormone in children with idiopathic short stature.
    Luo X, Zhao S, Yang Y, Dong G, Chen L, Li P, Luo F, Gong C, Xu Z, Xu X, Gong H, Du H, Hou L, Zhong Y, Shi Q, Chen X, Chen X, Xu L, Cheng R, Su C, Ma Y, Xu L, Zhang L, Lu H.
    Eur J Endocrinol; 2022 Nov 01; 187(5):709-718. PubMed ID: 36130048
    [Abstract] [Full Text] [Related]

  • 14. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L, Zou CC, Li Y, Wang CL, Jiang YJ, Dong GP, Fu JF, Wang XM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 01; 44(9):657-61. PubMed ID: 17217656
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
    Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, Phillip M, Kim HS, Ko C, Malievskiy O, Cara JF, Roland CL, Taylor CT, Valluri SR, Wajnrajch MP, Pastrak A, Miller BS.
    J Clin Endocrinol Metab; 2022 Jun 16; 107(7):e2717-e2728. PubMed ID: 35405011
    [Abstract] [Full Text] [Related]

  • 16. Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study.
    Qiao Y, Wang Z, Han J, Li G.
    Int J Endocrinol; 2019 Jun 16; 2019():1438723. PubMed ID: 31641350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, Van Aelst A, De Rijdt D, Stevenaert A, Beckers A.
    Clin Endocrinol (Oxf); 1997 Oct 16; 47(4):485-94. PubMed ID: 9404448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, Hoffman AR.
    Endocr Pract; 2019 Nov 16; 25(11):1191-1232. PubMed ID: 31760824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.